|
TP1878L |
PACAP 1-38 acetate
|
|
PACAP
|
|
PACAP 1-38 acetate is a pituitary adenylate cyclase activating polypeptide (PACAP) analogue. PACAP 1-38 acetate binds to PACAP type I receptor(IC50 = 4 nM) and PACAP type II VIP2 receptor(IC50 = 1 nM) but not to PACAP ty... |
|
TP1070L |
PACAP (1-27), human, ovine, rat acetate
|
PACAP 1-27 acetate,PACAP (1-27), human, ovine, rat acetate(127317-03-7 free base) |
PACAP
|
|
PACAP (1-27), human, ovine, rat acetate (PACAP 1-27 acetate) is a novel neuropeptides originally isolated from bovine hypothalamus, also found in humans and rats. |
|
TP1618L |
PACAP-38 (31-38), human, mouse, rat acetate
|
PACAP-38 (31-38), human, mouse, rat acetate(138764-85-9 Free base) |
PACAP
|
|
PACAP-38 (31-38), human, mouse, rat acetate is an activator of PAC1 receptor. PACAP-38 (31-38), human, mouse, rat acetate demonstrates potent, efficacious, and sustained stimulatory effects on sympathetic neuronal NPY an... |
|
TP1722L |
PACAP (6-38), human, ovine, rat acetate
|
|
PACAP
|
|
PACAP (6-38), human, ovine, rat acetate is a potent PACAP receptor antagonist with IC50s of 30, 600, and 40 nM for PACAP type I receptor, PACAP type II receptor VIP1, and PACAP type II receptor VIP2, respectively. |
|
TP1070 |
PACAP (1-27), human, ovine, rat
|
PACAP 1-27 |
|
|
PACAP (1-27) (the N-terminal fragment of PACAP-38) is a novel neuropeptides originally isolated from bovine hypothalamus, also found in humans and rats. |
|
TP1069 |
PACAP (1-27), human, ovine, rat TFA
|
PACAP 1-27 TFA |
|
|
PACAP (1-27), human, ovine, rat TFA (PACAP 1-27 TFA) is an N-terminal fragment of pacap-38 and an effective PACAP receptor antagonist. The IC50s for rat PAC1, rat VPAC1 and human VPAC2 are 3nm, 2nm and 5nm respectively. |
|
T83510 |
[Arg-15,20,21,Leu17]-PACAP-Gly-Lys-Arg-NH2
|
BM-PACAP |
|
|
[Arg-15,-20,-21, Leu17]-PACAP-Gly-Lys-Arg-NH2 (BM-PACAP) is a synthetic analogue of PACAP 1-27 that exhibits a relaxant effect [1]. |
|
TP1878 |
PACAP (1-38), human, ovine, rat
|
Pituitary Adenylate Cyclase Activating Polypeptide 38,PACAP 1-38 |
PACAP
|
|
PACAP (1-38), human, ovine, rat (Pituitary Adenylate Cyclase Activating Polypeptide 38) is a neuropeptide with 38 amino acid residues. |
|
T36428 |
PACAP-related Peptide (human) (trifluoroacetate salt)
|
|
PACAP
|
|
PACAP-related peptide (PRP) is an endogenous 29-amino acid peptide that belongs to the secretin/glucagon superfamily of peptides, which includes secretin , glucagon , glucagon-like peptide-1 , GLP-2 , and pituitary adeny... |
|
T37435 |
PACAP-related Peptide (rat) (trifluoroacetate salt)
|
|
PACAP
|
|
PACAP-related peptide (PRP) is an endogenous 29-amino acid peptide that belongs to the secretin/glucagon superfamily of peptides, which includes secretin , glucagon , glucagon-like peptide-1 , GLP-2 , and pituitary adeny... |
|
TP1722 |
PACAP (6-38), human, ovine, rat
|
|
|
|
PACAP (6-38), human, ovine, rat is a potent antagonist of PACAP 38. PACAP (6-38) is much more potent and selective than PACAP (6-27) in the inhibition of PACAP-27-stimulated pituitary adenylate cyclase. |
|
TP1438 |
PACAP (6-38), human, ovine, rat TFA
|
|
|
|
PACAP (6-38), human, ovine, rat TFA is a potent PACAP receptor antagonist with IC50s of 30, 600, and 40 nM for PACAP type I receptor, PACAP type II receptor VIP1, and PACAP type II receptor VIP2, respectively. |
|
TP1850 |
PACAP-Related Peptide (PRP), human
|
|
|
|
PACAP-Related Peptide (PRP), human,a 29 amino-acid region of the PACAP precursor protein, is synthesized in quantities sufficient for biological and structural studies. |
|
T36427 |
PACAP (6-27) (human, chicken, mouse, ovine, porcine, rat) (trifluoroacetate salt)
|
|
PACAP
|
|
Pituitary adenylate cyclase-activating peptide (PACAP) (6-27) is a PACAP receptor antagonist with IC50 values of 1,500, 600, and 300 nM, respectively, for rat PAC1, rat VPAC1, and human VPAC2 recombinant receptors expres... |
|
TP1618 |
PACAP-38 (31-38), human, mouse, rat
|
|
|
|
PACAP-38 (31-38), human, mouse, rat demonstrates potent, efficacious, and sustained stimulatory effects on sympathetic neuronal NPY and catecholamine production. |
|
TP1619 |
PACAP-38 (16-38), human, mouse, rat
|
|
|
|
PACAP-38 (16-38), human, mouse, rat demonstrates potent, efficacious, and sustained stimulatory effects on sympathetic neuronal NPY and catecholamine production. |
|
TP1054 |
PACAP (1-38), human, ovine, rat TFA
|
Pituitary Adenylate Cyclase Activating Polypeptide 38 (TFA) |
|
|
PACAP (1-38), a novel neuropeptide isolated from the bovine hypothalamus is more active than vasoactive intestinal peptide (VIP) in stimulating adenylate cyclase (EC50=7 nM). PACAP 1-38 (10-9 M) increased substance P (SP... |
|
TP1414 |
PACAP-38 (31-38), human, mouse, rat TFA
|
|
|
|
PACAP-38 (31-38), human, mouse, rat (TFA) demonstrates potent, efficacious, and sustained stimulatory effects on sympathetic neuronal. |
|
T81572 |
PACAP (1-38) free acid
|
|
|
|
PACAP (1-38) free acid, an endogenous neuropeptide, potently modulates gastrointestinal and neuroendocrine functions. It enhances antral motility, increases somatostatin secretion, and stimulates the release of vasoactiv... |
|
T80069 |
PACAP (6-27) (human, ovine, rat)
|
Pituitary adenylate cyclase-activating peptide (6-27) |
|
|
PACAP (6-27) (human, ovine, rat) serves as an antagonist for the PACAP receptor, inhibiting the catecholamine response of the canine adrenal gland to vasoactive intestinal peptide (VIP). This compound holds promise for r... |
|
T81571 |
PACAP (1-38) free acid TFA
|
|
|
|
PACAP (1-38) free acid TFA, an endogenous neuropeptide, effectively enhances antral motility and somatostatin secretion, while concurrently suppressing gastrin secretion and promoting the release of vasoactive intestinal... |
|
T41005 |
PA-8
|
|
PACAP
|
|
PA-8 is a small molecule receptor antagonist for PACAP Type I (PAC1) that is selective, effective, and orally active. PA-8 inhibits PacAP-induced CREB phosphorylation at PAC1- receptors, but does not inhibit VPAC1- or vp... |
|
T78105 |
PAC1R antagonist 1
|
|
PACAP
|
|
PAC1R antagonist 1 is an orally active PAC1 receptor antagonist that inhibits abnormal pain induced by pituitary adenylate cyclase-activating polypeptide (PACAP) and nerve damage, and may be used in the study of neoplasm... |
|
T76949 |
Zelminemab
|
|
|
|
Zelminemab (AMG-301) is a human monoclonal antibody designed to target and inhibit the PACAP type I (PAC1) receptor [1]. |
